[go: up one dir, main page]

BR9810280A - Pós de prolipossomo para inalação estabelizada por tocoferol. - Google Patents

Pós de prolipossomo para inalação estabelizada por tocoferol.

Info

Publication number
BR9810280A
BR9810280A BR9810280-0A BR9810280A BR9810280A BR 9810280 A BR9810280 A BR 9810280A BR 9810280 A BR9810280 A BR 9810280A BR 9810280 A BR9810280 A BR 9810280A
Authority
BR
Brazil
Prior art keywords
tocopherol
inhalation
established
powder
proliposome
Prior art date
Application number
BR9810280-0A
Other languages
English (en)
Portuguese (pt)
Inventor
Katarina Bystroem
Per-Gunnar Nilsson
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of BR9810280A publication Critical patent/BR9810280A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Otolaryngology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9810280-0A 1997-06-27 1998-06-08 Pós de prolipossomo para inalação estabelizada por tocoferol. BR9810280A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US88441997A 1997-06-27 1997-06-27
PCT/SE1998/001090 WO1999000111A1 (fr) 1997-06-27 1998-06-08 Poudres de proliposomes stabilisees par tocopherol et destinees a l'inhalation

Publications (1)

Publication Number Publication Date
BR9810280A true BR9810280A (pt) 2000-09-12

Family

ID=25384589

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9810280-0A BR9810280A (pt) 1997-06-27 1998-06-08 Pós de prolipossomo para inalação estabelizada por tocoferol.

Country Status (18)

Country Link
EP (1) EP1001749A1 (fr)
JP (1) JP2002510311A (fr)
KR (1) KR20010014163A (fr)
CN (1) CN1260713A (fr)
AU (1) AU729100B2 (fr)
BR (1) BR9810280A (fr)
CA (1) CA2295028A1 (fr)
EE (1) EE9900601A (fr)
HU (1) HUP0003207A3 (fr)
ID (1) ID23192A (fr)
IL (1) IL133478A0 (fr)
IS (1) IS5304A (fr)
NO (1) NO996439L (fr)
NZ (1) NZ501672A (fr)
PL (1) PL337723A1 (fr)
SK (1) SK184899A3 (fr)
TR (1) TR199903271T2 (fr)
WO (1) WO1999000111A1 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
EP1138311A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138313A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
EP1138310A1 (fr) * 2000-03-28 2001-10-04 Primacare S.A. Proliposomes
CA2608631C (fr) * 2005-06-09 2014-07-29 Biolipox Ab Methode et composition de traitement de troubles inflammatoires
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
KR102339146B1 (ko) * 2013-05-06 2021-12-15 디에스엠 아이피 어셋츠 비.브이. 분말형 비타민 e 제형
US20170246187A1 (en) 2014-08-28 2017-08-31 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
CN105078963B (zh) * 2015-09-29 2018-06-22 中山大学 α-生育酚在制备治疗血吸虫病药物中的应用
JP2020503269A (ja) 2016-11-28 2020-01-30 リポカイン インコーポレーテッド 経口ウンデカン酸テストステロン療法
CA3107214A1 (fr) 2018-07-20 2020-01-23 Lipocine Inc. Maladie du foie

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7908791A (en) * 1990-05-08 1991-11-27 Liposome Technology, Inc. Direct spray-dried drug/lipid powder composition
SA95160463B1 (ar) * 1994-12-22 2005-10-04 استرا أكتيبولاج مساحيق للاستنشاق

Also Published As

Publication number Publication date
CA2295028A1 (fr) 1999-01-07
CN1260713A (zh) 2000-07-19
ID23192A (id) 2000-03-23
TR199903271T2 (en) 2000-08-21
HUP0003207A3 (en) 2001-03-28
EP1001749A1 (fr) 2000-05-24
SK184899A3 (en) 2000-05-16
NO996439D0 (no) 1999-12-23
IL133478A0 (en) 2001-04-30
AU729100B2 (en) 2001-01-25
WO1999000111A1 (fr) 1999-01-07
IS5304A (is) 1999-12-15
EE9900601A (et) 2000-08-15
NO996439L (no) 2000-02-28
PL337723A1 (en) 2000-08-28
HUP0003207A2 (hu) 2001-02-28
NZ501672A (en) 2001-06-29
KR20010014163A (ko) 2001-02-26
JP2002510311A (ja) 2002-04-02
AU7945698A (en) 1999-01-19

Similar Documents

Publication Publication Date Title
BR9810280A (pt) Pós de prolipossomo para inalação estabelizada por tocoferol.
BR9811249A (pt) Nova formulação para inalação; apresentando densidade volumétrica, quando derramada, de 0,20 à 0,38g/ml, processo para preparação de formulação e uso da mesma
ES2194931T3 (es) Composicion farmaceutica que contiene polvos de proliposomas, destinada a la inhalacion.
MX22877A (es) Procedimiento para la preparacion de pirimidas, producto obtenido y composicion farmaceutica que lo incluye
YU49279B (sh) Postupak za pripremanje farmaceutske formulacije za dobijanje leka za inhalacionu primenu
DK440386A (da) Laegemiddelholdigt chlorfluorcarbon-aerosoldrivmiddelpraeparat
BR9703624A (pt) Combinação formulação farmacêutica processo para o tratamento de depressão em um animal uso de mirtazapina uso de um ou mais srri's e embalagem
BR9609447A (pt) Composto formulação farmacêutica uso de um composto e processos para preparação de um composto e tratamento de uma condição em que é necessária trombina
BR9916587A (pt) Aparelho e processo para preparar partìculas cristalinas de uma substância, população de partìculas, composição farmacêutica e partìculas cristalinas de 2,6-diamino-3-(2,3,5-triclorofenil)-pirazina
BG103221A (en) Pharmaceutical composition in aerosol form
BR9809328A (pt) Processo para preparação de formas sólidas de medicamentos empregáveis peroralmente com desprendimento controlado de substância ativa
AU4151099A (en) Cosmetic or dermopharmaceutical composition in the form of beads and methods forpreparing same
IL105944A (en) Phospholipid-containing cosmetic preparation and its production
BR9602922A (pt) Composição mistura estabilizadora uso e processo para a preparação de um polímero
CA2216320A1 (fr) Emulsions stables et poudres seches de melanges de vitamines liposolubles, leur preparation et leur utilisation
PT101725A (pt) Processo para a preparacao de um composto de diarilo anti-aterosclerotico e de composicoes farmaceuticas que o contem
BR9914800A (pt) Preparação e uso de óleos solidificados
HUP9900365A2 (hu) N-Aril-1,2,4-triazolin-5-on-származékok, előállításuk és alkalmazásuk, a vegyületeket hatóanyagként tartalmazó inszekticid, arachnicid és nematocid készítmények
BR9915215A (pt) Composição farmacêutica para liberação modificada de sensibilizador de insulina
DE68905613D1 (de) Pharmazeutische zubereitung.
ATE235219T1 (de) Kosmetische zubereitungen
AU4480889A (en) A pharmaceutical composition for rapid release of the active component comprising an orderred mixture and a surfactant
AU7775398A (en) Novel glycosylated ginkgolide derivatives, their application as medicines and pharmaceutical compositions
ES2059869T3 (es) Preparado farmaceutico que contiene piroxicam para uso topico.
BR9812120A (pt) Derivados de 9h-1, 3-dioxolo/4, 5-h// 2,3 /benzodiazepina 8, composição farmacêutica eprocesso para sua preparação

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A,8A E 9AANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.